HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D J Biedenbach Selected Research

beta-Lactamases (beta-Lactamase)

8/2001In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D J Biedenbach Research Topics

Disease

5Infections
12/2016 - 01/2000
2Respiratory Tract Infections (Respiratory Tract Infection)
12/2016 - 05/2001
1Bacterial Pneumonia
12/2016
1Urinary Tract Infections (Urinary Tract Infection)
01/2016
1Intraabdominal Infections
05/2014
1Whooping Cough (Pertussis)
12/2001
1Bronchitis
06/2000
1Pharyngitis (Sore Throat)
06/2000
1Pneumonia (Pneumonitis)
06/2000
1Sinusitis
06/2000
1Bacteremia
03/2000
1Substance-Related Disorders (Drug Abuse)
03/2000
1Acquired Immunodeficiency Syndrome (AIDS)
03/2000

Drug/Important Bio-Agent (IBA)

2Anti-Infective Agents (Microbicides)IBA
01/2016 - 12/2001
2Tigecycline (Tygacil)FDA Link
05/2014 - 08/2001
2cefditorenIBA
05/2001 - 06/2000
1Ceftriaxone (Ceftriaxon)FDA LinkGeneric
12/2016
1tedizolidIBA
12/2016
1CeftarolineFDA Link
12/2016
1Erythromycin (Erycette)FDA LinkGeneric
12/2001
1FluoroquinolonesIBA
12/2001
1Gatifloxacin (Zymar)FDA Link
12/2001
1beta-Lactamases (beta-Lactamase)IBA
08/2001
1Anti-Bacterial Agents (Antibiotics)IBA
08/2001
1Cephalosporins (Cephalosporin Antibiotics)IBA
06/2000
1Penicillins (Penicillin)FDA Link
06/2000
1VancomycinFDA LinkGeneric
03/2000
1CreatinineIBA
03/2000
1Azithromycin (Zithromax)FDA LinkGeneric
01/2000

Therapy/Procedure

1Length of Stay
09/2014
1Liver Transplantation
03/2000